Eur Thyroid J (2019) 8(6):30711
The FDA-approved prescribing information doesn't require a tapering protocol, and medications can be stopped without dose reduction
Notably, individuals with PD and coexisting metabolic comorbgidities such as insulin resistance or obesity appear to derive greater clinical and cognitive benefits from GLP-1 RA therapy [62, 63]
Elevated cAMP activates protein kinase A (PKA), which phosphorylates multiple targets including ion channels, transcription factors (notably CREB), and components of the insulin secretory machinery
These findings mark a major advancement in expanding therapeutic options for individuals with obesity
While semaglutide can be a valuable tool for weight loss, its not a magic solution